Tozorakimab 1
D9180C00008
Phase 3 other active
Quick answer
Tozorakimab 1 for Chronic Obstructive Pulmonary Disease (COPD) is a Phase 3 program (other) at AstraZeneca with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- Chronic Obstructive Pulmonary Disease (COPD)
- Phase
- Phase 3
- Modality
- other
- Status
- active